BMY vs NEGG · P/E 17, rev $24.46B vs rev $1.44B
Bristol-Myers Squibb Company (BMY) versus Newegg Commerce Inc (NEGG) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Newegg Commerce Inc (NEGG) is a internet retail company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported NEGG revenue for 2025-12-31 was $1.44B. Net income was -$4.9M. Revenue was up 16.9% from 2024-12-31 to 2025-12-31. NEGG currently screens at market cap $959.1M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. NEGG currently screens at market cap $959.1M.
Not investment advice. Open the BMY and NEGG stock pages for the full models.
Not investment advice.